Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MYL5 |
| Upstream (Parents) |
|---|
| (<<) ATP2C1 → MYL5 |
| (<<) BBS1 → MYL5 |
| (<<) CAMKK2 → MYL5 |
| (<<) CASP3 → MYL5 |
| (<<) CREB1 → MYL5 |
| (<<) E2F3 → MYL5 |
| (<<) HEY1 → MYL5 |
| (<<) ITGAV → MYL5 |
| (<<) MLX → MYL5 |
| (<<) NR3C1 → MYL5 |
| (<<) PLA2G4C → MYL5 |
| (<<) PRR5 → MYL5 |
| (<<) RBP1 → MYL5 |
| (<<) STX12 → MYL5 |
| (<<) TNF → MYL5 |
| (<<) TYK2 → MYL5 |
| Downstream (Children) |
|---|
| MYL5 → CABC1 (>>) |
| MYL5 → CHODL (>>) |
| MYL5 → CTRB2 (>>) |
| MYL5 → ELF5 (>>) |
| MYL5 → EPHA1 (>>) |
| MYL5 → GSTK1 (>>) |
| MYL5 → HS3ST2 (>>) |
| MYL5 → MAN2A2 (>>) |
| MYL5 → PLCD1 (>>) |
| MYL5 → PLD2 (>>) |
| MYL5 → PTPN11 (>>) |
| MYL5 → RB1 (>>) |
| MYL5 → RGS20 (>>) |
| MYL5 → SLC6A14 (>>) |
| MYL5 → SOX1 (>>) |
